FMII
CHRS icon

Farmers & Merchants Investments Inc’s Coherus Oncology CHRS Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-40
Closed -$171 – 1764
2023
Q2 		$171 Hold
40
– – ﹤0.01% 1733
2023
Q1 		$274 Hold
40
– – ﹤0.01% 1685
2022
Q4 		$317 Hold
40
– – ﹤0.01% 1692
2022
Q3 		$0 Buy
+40
New +$405 ﹤0.01% 1579
2020
Q2 		– Sell
-414
Closed -$7K – 848
2020
Q1 		$7K Hold
414
– – ﹤0.01% 565
2019
Q4 		$7K Buy
414
+174
+73% +$3.21K ﹤0.01% 670
2019
Q3 		$5K Buy
+240
New +$4.79K ﹤0.01% 714

Other funds holding CHRS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Farmers & Merchants Investments Inc's CHRS Position: Q3 2023 in Review

Farmers & Merchants Investments Inc sold out of Coherus Oncology (CHRS) in Q3 2023, closing a stake of 40 shares — an estimated $171 sold.

Farmers & Merchants Investments Inc first reported a position in CHRS in Q3 2019 and held it in 7 quarters. The position peaked at $7K in Q1 2020. 169 funds tracked by Wall St. Rank hold CHRS as of Q3 2023.

  • Farmers & Merchants Investments Inc reported no remaining Coherus Oncology position as of Q3 2023 after selling out during the quarter.
  • Farmers & Merchants Investments Inc sold 40 Coherus Oncology shares in Q3 2023, an estimated $171.
  • Farmers & Merchants Investments Inc first reported a position in Coherus Oncology in Q3 2019 and held it in 7 quarters.
  • Farmers & Merchants Investments Inc's Coherus Oncology position peaked at $7K in Q1 2020.
  • 169 funds tracked by Wall St. Rank held Coherus Oncology as of Q3 2023.

Based on Farmers & Merchants Investments Inc's 13F filing for Q3 2023, filed 25 Oct 2023.